Second, binding of toxic oligomeric protein species, such as PrPSc (in prion diseases [38]), Aβ (in Alzheimer’s disease [39–42]) or α-synuclein (in Parkinson’s disease [43, 44]), to PrPC at the neuronal surface results in neurotoxic signaling. The gene discussed is PRNP; the disease is prion disease.